Microbial spectrum of urine before and after transurethral procedures on the prostate in patients with postoperative urinary tract infections

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Aim. To evaluate the microbial spectrum of urine before and after transurethral resection of prostate (TURP) in patients with postoperative infectious complications.

Materials and methods. A single-center retrospective observational study between 2016 and 2023 was carried out. Patients who developed urinary tract infections (UTIs) after mono- or bipolar TURP during the hospitalization were included. Bacteriological examination of urine obtained before procedure and after the manifestation of UTI was done in accordance with the Guidelines. In the presence of suprapubic or urethral catheter, the drainage was previously replaced with further microbiological study. The level of significant bacteriuria was ≥ 103 CFU/ml, with a level of significant leukocyturia ≥ 10 per field of view. Statistical analysis was carried out using IBM SPSS Statistics 23.0.

Results. Bacteriuria was not detected in 77.9% of cases of UTIs after TURP. At the same time, according to the preoperative examination in 76.2% of these patients, there was no bacteriuria ≥ 103 CFU/ml. In 17 of 122 men (13.9%) without bacteriuria at baseline, microorganisms were isolated after the development of UTIs. A decrease in bacteriuria level was noted in only 19 of 29 patients (65.5%) who had a positive urine culture before TURP. Only in 4 out of 10 cases of persistent bacteriuria the same microorganism was isolated, while in the remaining 6 cases the initial spectrum was replaced by another bacteria.

Conclusion. Our data indicate a low detection rate of microorganisms in urine of patients with UTIs after TURP using a standard bacteriological study. The data indicate that the standard antibiotic prophylaxis regimen and ongoing anti-infective measures are partly effective in reducing a narrow range of aerobic microorganisms detected preoperatively using standard media, which, however, does not exclude the development of an infectious process.

Толық мәтін

Рұқсат жабық

Авторлар туралы

M. Kogan

FGBOU VO Rostov State Medical University of the Ministry of Health of the Russian Federation

Email: kogan_dept@mail.ru
ORCID iD: 0000-0002-1710-0169

Honored Scientist of Russian Federation, Ph.D., MD, professor, Head of the Department of Urology and Human Reproductive Health with the course of pediatric urology and andrology

Ресей, Rostov-on-Don

V. Medvedev

FGBOU VO Kuban State Medical University of the Ministry of Health of the Russian Federation; Scientific and Research Institute of the Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky

Email: medvedev_vl@mail.ru
ORCID iD: 0000-0001-8335-2578

Honored Scientist of Russian Federation, Ph.D., MD, professor, Deputy Chief on Urology of GBUZ Scientific and Research Institute of Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky, Chief Urologist of the Ministry of Health of Kuban Region, Head of the Uronephrologic Center of Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky

Ресей, Krasnodar; Krasnodar

Yu. Naboka

FGBOU VO Rostov State Medical University of the Ministry of Health of the Russian Federation

Email: nula33@mail.ru
ORCID iD: 0000-0002-0937-4573

Ph.D., MD, professor, Head of the Department of Microbiology and Virology No.1

Ресей, Rostov-on-Don

S. Ivanov

FGBOU VO Rostov State Medical University of the Ministry of Health of the Russian Federation

Хат алмасуға жауапты Автор.
Email: ivanovsergey19@gmail.com
ORCID iD: 0000-0002-9772-937X

Ph.D. student 

Ресей, Rostov-on-Don

G. Palaguta

FGBOU VO Kuban State Medical University of the Ministry of Health of the Russian Federation; Scientific and Research Institute of the Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky

Email: palaguta83@gmail.com
ORCID iD: 0000-0002-3462-8766

assistant at the Department of Urology, Kuban State Medical University; urologist at the Urologic Department No 1, Scientific and Research Institute of the Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky

Ресей, Krasnodar; Krasnodar

M. Arkhipenko

Scientific and Research Institute of the Regional Clinical Hospital №1 named after prof. S.V. Ochapovsky

Email: arxipenko.m@mail.ru
ORCID iD: 0009-0005-0859-0804

Head of the bacteriological laboratory 

Ресей, Krasnodar

Әдебиет тізімі

  1. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
  2. Köves B., Tenke P., Tandogdu Z., Cai T., Bogenhard F., Wullt B., Naber K., Bartoletti R., Cek M., Kulchavenya E., Perepanova T., Pilatz A., Bonkat G., Wagenlehner F. Transurethral Resection of the Prostate: are We Following the Guidelines? - Outcomes from the Global Prevalence of Infections in Urology (GPIU) Study. J Chemother. 2019;31(1):15–22. doi: 10.1080/1120009X.2018.1542552. PMID: 30508403.
  3. Bruyère F., Perennec-Olivie M., Tanguy J., Aupee M., Astagneau P., Jarno P., Malavaud S. Surgical site infection after trans urethral resection of the prostate (TURP): 2008-2013 French national SSI surveillance ISO-RAISIN. J Infect Prev. 2018;19(4):178–183. doi: 10.1177/1757177418755307. PMID: 30013622; PMCID: PMC6039909.
  4. Kozlov R.S. Bakteriologicheskij analiz mochi klinicheskie rekomendacii/R.S. Kozlov, V.V. Men’shikov, V.S. Mihajlova, B.F. Shuljak, T.I. Dolgih, A.N. Kruglov, E.V. Alieva, V.E. Malikova – Klinicheskie rekomendacii. – M.. 2014. Russian (Козлов Р.С. Бактериологический анализ мочи клинические рекомендации/Р.С. Козлов, В.В. Меньшиков, В.С. Михайлова, Б.Ф. Шуляк, Т.И. Долгих, А.Н. Круглов, Е.В. Алиева, В.Е. Маликова – Клинические рекомендации. – М., 2014.).
  5. Ahmed S.S., Shariq A., Alsalloom A.A., Babikir I.H., Alhomoud B.N. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci (Qassim). 2019;13(2):48–55. PMID: 30983946; PMCID: PMC6436442.
  6. Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Pol J Microbiol. 2019;68(4):403–415. doi: 10.33073/pjm-2019-048. Epub 2019;5. PMID: 31880885; PMCID: PMC7260639.
  7. Grabe M. Antimicrobial Agents in Transurethral Prostatic Resection. The Journal of Urology. 1987;138(2), 245–252. doi: 10.1016/s0022-5347(17)43109.
  8. Osman T., ElSaeed K.O., Youssef H.A., Shabayek M., Emam A., Hussein M.S. Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria. Arab J Urol. 2017;15(3):260–266. doi: 10.1016/j.aju.2017.05.004.
  9. Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention. European Urology. 2005;50(5), 969–980. doi: 10.1016/j.eururo.2005.12.042
  10. Kikuchi M., Kameyama K., Yasuda M., Yokoi S., Deguchi T., Miwa K. Postoperative infectious complications in patients undergoing holmium laser enucleation of the prostate: Risk factors and microbiological analysis. Int J Urol. 2016;23(9):791–796. doi: 10.1111/iju.13139.
  11. Agbugui J.O., Obarisiagbon E.O., Osaigbovo I.I. Bacteriology of Urine Specimens Obtained from Men with Symptomatic Benign Prostatic Hyperplasia. Niger J Surg. 2016;22(2):65–69. doi: 10.4103/1117-6806.177415.
  12. Vennila R.B., Natesan S. Asymptomatic Bacteriuria in Patients with Benign Prostate Hypertrophy before Transurethral Resection of Prostate (Turp).Int.J.Curr.Microbiol.App.Sci. 2019;8(4): 1987–1995. Doi: https://doi.org/10.20546/ijcmas.2019.804.232.
  13. Stangl-Kremser J., Brönimann S., Abufaraj M., Pozo C., Shariat S., et al. Risk Factors for Urinary Tract Infection in Men Treated with Transurethral Resection of the Prostate for Lower Urinary Tract Symptoms. Int Arch Urol Complic. 2019;5:062. doi.org/10.23937/2469-5742/1510062
  14. May A., Broggi E., Lorphelin H., Tabchouri N., Giretti G., Pereira H., Bruyere F. Comparison of the risk of postoperative infection between transurethral vaporesection and transurethral resection of the prostate. Lasers in Surgery and Medicine. 2014;46(5), 405–411. doi: 10.1002/lsm.22240
  15. Wagenlehner F.M.E., Wagenlehner C., Schinzel S., Naber K.G. Prospective, Randomized, Multicentric, Open, Comparative Study on the Efficacy of a Prophylactic Single Dose of 500mg Levofloxacin versus 1920mg Trimethoprim/Sulfamethoxazole versus a Control Group in Patients Undergoing TUR of the Prostate. European Urology. 2005;47(4), 549–556. doi: 10.1016/j.eururo.2005.01.004.
  16. Hwang E.C., Yu S.H., Kim J.B., Jung S.I., Kang T.W., Kwon D.D., Park K. Risk Factors of Infectious Complications after Transurethral Prostate Surgery in Patients with Preoperative Sterile Urine. The Korean Journal of Urogenital Tract Infection and Inflammation, 2013;8(1), 27.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
2. Fig 1. Detectability of microorganisms in urine before and after surgery in the development of infectious complications

Жүктеу (200KB)
3. Fig 2. Bar graphs of bacteriuria detection before and after surgery

Жүктеу (343KB)
4. Fig 3. Combined plot of bacteriuria spectrum before and after surgery

Жүктеу (474KB)

© Bionika Media, 2024

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>